Pulmonary toxicity associated with treatment with amiodarone
DOI:
https://doi.org/10.32818/reccmi.a4n2a6Keywords:
amiodarone, pulmonary toxicity, pulmonary infiltrates, organized pneumonia.Abstract
Amiodarone is a widely used antiarrhythmic. Its continued use and the accumulated dose increase the possibility of side effects, mainly thyroid disease, acute toxic hepatitis and pulmonary toxicity. The pulmonary affectation by amiodarone appears in around 5-10% of the patients that use this drug. The organized pneumonia is the most common form of affectation. It can present as interstitial pneumonitis, respiratory distress syndrome (ARDS) or pulmonary or pleural nodules. The delay in diagnosis and withdrawal of the drug plays a fundamental role in its resolution.
Downloads
Metrics
References
Sánchez S, Zamora E, Hoyos N, Naranjo A, Al-Nakeeb Z, Girón RM. Fibrosis pulmonar por amiodarona. Rev Patol Respir. 2006; 9(2): 77-80.
Wolkove N, Baltzan M. Amiodarone pulmonary toxicity. Can Respir J. 2009; 16(2): 43-48. doi: https://doi.org/10.1155/2009/282540.
Skeoch S, Weatherley N, Swift AJ, Oldroyd A, Johns C, Hayton C, et al. Drug induced interstitial lung disease: a systematic review. J Clin Med. 2018; 7(10). pii: E356. doi: https://doi.org/10.3390/jcm7100356.
Jackevicius CA, Tom A, Essebag V, Eisenberg MJ, Rahme E, Tu JV, et al. Population level incidence and risk factors for pulmonary toxicity associated with amiodarone. Am J Cardiol. 2011 Sep 1; 108(5): 705-710. doi: https://doi.org/10.1016/j.amjcard.2011.04.024.
Martin WJ, Rosenow EC. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I). Chest. 1988; 93(5): 1067-1075. doi: https://doi.org/10.1378/chest.93.5.1067.
Papiris SA, Triantafillidou C, Kolilekas L, Markoulaki D, Manali ED. Amiodarone: review of pulmonary effects and toxicity. Drug Saf. 2010; 33(7): 539-558. doi: https://doi.org/10.2165/11532320-000000000-00000.
Mankikian J, Favelle O, Guillon A, Guilleminault L, Cormier B, Jonville-Béra AP, et al. Initial characteristics and outcome of hospitalized patients with amiodarone pulmonary toxicity. Respir Med. 2014; 108(4): 638-646. doi: https://doi.org/10.1016/j.rmed.2014.01.014.
Camus P, Martin WJ, Rosenow EC. Amiodarone pulmonary toxicity. Clin Chest Med. 2004 Mar; 25(1): 65-75. doi: https://doi.org/10.1016/S0272-5231(03)00144-8.
Colby R, Geyer H. Amiodarone induced pulmonary toxicity. JAAPA. 2017; 30(11): 23-26. doi: https://doi.org/10.1097/01.JAA.0000524713.17719.c8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Jesús Lancha-Domínguez, María del Mar Ramírez-Sánchez, María Inmaculada Páez-Rubio
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
